Institute of Tropical Medicine Antwerp
Foundation of Public Utility

HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme [letter]

DSpace/Manakin Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)